1-4 of 4
Jill R. Crittenden
Close
Sort by
Journal Articles

CalDAG-GEFI and Protein Kinase C (PKC) Represent Alternative Pathways Leading to Activation of Integrin αIIbβ3 in Platelets.

Wolfgang Bergmeier, PhD, Jill R. Crittenden, Ph.D., Crystal L. Piffath, Stephen M. Cifuni, Denisa D. Wagner, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 3646.
https://doi.org/10.1182/blood.V110.11.3646.3646
Published: 2007
Journal Articles

Mice Lacking the Signaling Molecule, CalDAG-GEFI, Represent a Mouse Model for Leukocyte Adhesion Deficiency Type III.

Wolfgang Bergmeier, PhD, Tobias Goerge, M.D., Hong-Wei Wang, Ph.D., Stephen M. Cifuni, Jill R. Crittenden, Ph.D., Ann M. Graybiel, Ph.D., Denisa D. Wagner, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 674.
https://doi.org/10.1182/blood.V108.11.674.674
Published: 2006
Journal Articles

The small GTPase Rap1b regulates the cross talk between platelet integrin α 2 β 1 and integrin α IIb β 3

Bruno Bernardi, Gianni F. Guidetti, Francesca Campus, Jill R. Crittenden, Ann M. Graybiel, Cesare Balduini, Mauro Torti
Journal: Blood
Blood (2006) 107 (7): 2728–2735.
https://doi.org/10.1182/blood-2005-07-3023
Published: 2006
Journal Articles

CalDAG-GEFI Is a Key Signal Integrator in Platelet Activation and Thrombus Formation.

Wolfgang Bergmeier, Ph.D., Jill R. Crittenden, Ph.D., Crystal L. Piffath, Denisa D. Wagner, Ph.D., David E. Housman, Ph.D., Ann M. Graybiel, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 326.
https://doi.org/10.1182/blood.V104.11.326.326
Published: 2004